Use of beta blockers in various clinical states | Zendy

Vesna Radović | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Use of beta blockers in various clinical states

Author(s) -

Vesna Radović

Publication year - 2011

Publication title -

medicinski pregled

Language(s) - English

Resource type - Journals

eISSN - 1820-7383

pISSN - 0025-8105

DOI - 10.2298/mpns1102055r

Subject(s) - medicine , myocardial infarction , cardiology , beta (programming language) , diabetes mellitus , disease , angina , asthma , sudden death , infarction , unstable angina , endocrinology , computer science , programming language

According to the convincing evidence, a decline in mortality rate has been achieved with beta-blockers in patients with an acute myocardial infarction and in post-infarction follow-up. In fact, there has been a clear reduction of sudden coronary death. The necessary condition for the efficiency of beta-blockers is an early use. They are also a medication of choice for angina after an infarction. The objective of this work was to evaluate the use of beta-blockers after a myocardial infarction in various clinical states and to eliminate doubts concerning their prescription.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research